Evidence map›Paper›PMID 28942477›Full record

ArticleBrain imaging and behavior2019

Cognitive performance in mid-stage Parkinson's disease: functional connectivity under chronic antiparkinson treatment.

Roxana Vancea, Kristina Simonyan, Maria Petracca, Miroslaw Brys, Alessandro Di Rocco, Maria Felice Ghilardi, Matilde Inglese

Open access · greenAbstract read
In one paragraph

Article in Brain imaging and behavior, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Roxana VanceaDepartment of Neurology, Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place Box 1137, New York, NY, 10029, USA.
Kristina SimonyanDepartment of Neurology, Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place Box 1137, New York, NY, 10029, USA.
Maria PetraccaDepartment of Neurology, Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place Box 1137, New York, NY, 10029, USA.
Miroslaw BrysDepartment of Neurology, New York University School of Medicine, NYU Movement Disorders, 240 East 38th Street, 20th Floor, New York, NY, 10016, USA.
Alessandro Di RoccoDepartment of Neurology, New York University School of Medicine, NYU Movement Disorders, 240 East 38th Street, 20th Floor, New York, NY, 10016, USA.
Maria Felice GhilardiDepartment of Physiology and Pharmacology, City University of New York Medical School, 138th and Convent Ave, New York, NY, 10031, USA.
Matilde IngleseDepartment of Neurology, Icahn School of Medicine, Mount Sinai, One Gustave L. Levy Place Box 1137, New York, NY, 10029, USA. matilde.inglese@mssm.edu.
Icahn School of Medicine at Mount Sinai · USNew York University · USCity University of New York · USOspedale Policlinico San Martino · IT

Funding

Imaging genetics of spasmodic dysphoniaR01DC011805 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI Kristina Simonyan · 2012 to 2026
$8.8M
Voice tremor in spasmodic dysphonia: central mechanisms and treatment responseR01DC012545 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI SIMONYAN, KRISTINA · 2012 to 2021
$5.2M
Brain Networks in DystoniaR01NS088160 · NINDS · MASSACHUSETTS EYE AND EAR INFIRMARY · PI SIMONYAN, KRISTINA · 2015 to 2019
$2.4M
Consolidation of Motor Skills & Sleep Homeostasis in Parkinson's DiseaseR01NS054864 · NINDS · CITY COLLEGE OF NEW YORK · PI GHILARDI, M. FELICE MARINA · 2007 to 2011
$1.8M
Role of neurotransmission and functional CNS networks in spasmodic dysphoniaR00DC009629 · NIDCD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMONYAN, KRISTINA · 2009 to 2012
$955k
Fondazione Italiana Sclerosi Multipla 2013/B/7National Institutes of Health R01 NS054864NIDCD NIH HHS R00 DC009629NIDCD NIH HHS R01 DC011805NIDCD NIH HHS R01 DC012545NINDS NIH HHS R01 NS054864NINDS NIH HHS R01 NS088160
6 · The paper itself

Abstract

Cognitive impairment in Parkinson's disease (PD) is related to the reorganization of brain topology. Although drug challenge studies have proven how levodopa treatment can modulate functional connectivity in brain circuits, the role of chronic dopaminergic therapy on cognitive status and functional connectivity has never been investigated. We sought to characterize brain functional topology in mid-stage PD patients under chronic antiparkinson treatment and explore the presence of correlation between reorganization of brain architecture and specific cognitive deficits. We explored networks topology and functional connectivity in 16 patients with PD and 16 matched controls through a graph theoretical analysis of resting state-functional MRI data, and evaluated the relationships between network metrics and cognitive performance. PD patients showed a preserved small-world network topology but a lower clustering coefficient in comparison with healthy controls. Locally, PD patients showed lower degree of connectivity and local efficiency in many hubs corresponding to functionally relevant areas. Four disconnected subnetworks were also identified in regions responsible for executive control, sensory-motor control and planning, motor coordination and visual elaboration. Executive functions and information processing speed were directly correlated with degree of connectivity and local efficiency in frontal, parietal and occipital areas. While functional reorganization appears in both motor and cognitive areas, the clinical expression of network imbalance seems to be partially compensated by the chronic levodopa treatment with regards to the motor but not to the cognitive performance. In a context of reduced network segregation, the presence of higher local efficiency in hubs regions correlates with a better cognitive performance.

Indexed as

CognitionAntiparkinson AgentsBrainBrain MappingCognitive DysfunctionFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeural PathwaysParkinson DiseaseProspective StudiesRestAntiparkinson AgentsCognitionFunctional connectivityGraph theoryParkinson’s disease

Identifiers

PMID28942477
PMCPMC5866203
OpenAlexW2759677505

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.